A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus

NCT07433062 · clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
28
Enrollment
INDUSTRY
Sponsor class

Stopped Safety issue was identified in the Phase2b D7860C00006 study, evaluating AZD6793 in moderate to very severe COPD participants. D7860C00005 study is temporary halted to amend the design to reflect changes implemented in the ongoing D7860C00006 study

Conditions

Interventions

Sponsor

AstraZeneca